| Kriston Ronalter, PA | |
|
775 Queen Street, Southington, CT 06489 | |
| (860) 771-1281 | |
| Not Available |
| Full Name | Kriston Ronalter |
|---|---|
| Gender | Female |
| Speciality | Physician Assistant |
| Experience | 6 Years |
| Location | 775 Queen Street, Southington, Connecticut |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1396238960 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363AM0700X | Physician Assistant - Medical | (Connecticut) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| The Hospital Of Central Connecticut | New britain, CT | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| The Hospital Of Central Connecticut At New Britain General And Bradley | 6507776564 | 321 |
News Archive
Patients with advanced prostate cancer are often treated with hormones, but when the tumours start growing again they have more and different blood vessels, reveals a thesis from the Sahlgrenska Academy, at the University of Gothenburg, Sweden. This discovery paves the way for new treatments for hormone-resistant prostate cancer.
The Drugs for Neglected Diseases initiative (DNDi) and Medicines for Malaria Venture (MMV) announce today the identification of three chemical series targeting the treatment of deadly neglected tropical diseases (NTDs), through DNDi's screening of MMV's open access Malaria Box.
Scientists have revealed a way to eradicate parasitic worms by stopping them from using alternative metabolism pathways provided by bacteria that live within them, according to new findings published today in eLife.
Perosphere Inc. and Daiichi Sankyo Company, Limited (hereafter, Daiichi Sankyo) announced today that they have entered into a clinical trial agreement under which Daiichi Sankyo will support and co-sponsor a phase 1 clinical study testing the safety, tolerability and effectiveness of PER977 to reverse the anticoagulant activity of edoxaban, Daiichi Sankyo's investigational oral, once-daily, direct factor Xa-inhibitor.
Sanofi Pasteur, the vaccines division of Sanofi, today announced that the U.S. Food and Drug Administration has approved the supplemental biologics license application (sBLA) for Fluzone Intradermal Quadrivalent vaccine.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Kriston Ronalter, PA 1290 Silas Deane Hwy, Wethersfield, CT 06109-4337 Ph: () - | Kriston Ronalter, PA 775 Queen Street, Southington, CT 06489 Ph: (860) 771-1281 |
News Archive
Patients with advanced prostate cancer are often treated with hormones, but when the tumours start growing again they have more and different blood vessels, reveals a thesis from the Sahlgrenska Academy, at the University of Gothenburg, Sweden. This discovery paves the way for new treatments for hormone-resistant prostate cancer.
The Drugs for Neglected Diseases initiative (DNDi) and Medicines for Malaria Venture (MMV) announce today the identification of three chemical series targeting the treatment of deadly neglected tropical diseases (NTDs), through DNDi's screening of MMV's open access Malaria Box.
Scientists have revealed a way to eradicate parasitic worms by stopping them from using alternative metabolism pathways provided by bacteria that live within them, according to new findings published today in eLife.
Perosphere Inc. and Daiichi Sankyo Company, Limited (hereafter, Daiichi Sankyo) announced today that they have entered into a clinical trial agreement under which Daiichi Sankyo will support and co-sponsor a phase 1 clinical study testing the safety, tolerability and effectiveness of PER977 to reverse the anticoagulant activity of edoxaban, Daiichi Sankyo's investigational oral, once-daily, direct factor Xa-inhibitor.
Sanofi Pasteur, the vaccines division of Sanofi, today announced that the U.S. Food and Drug Administration has approved the supplemental biologics license application (sBLA) for Fluzone Intradermal Quadrivalent vaccine.
› Verified 1 days ago
Miranda Polaski, PA Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 81 Meriden Ave, Southington, CT 06489 Phone: 860-276-5000 | |
Mr. Vuong Duc Dang, PA Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 360 N Main St, Southington, CT 06489 Phone: 860-621-1024 | |
Rebecca Davies Jeffery, PA-C Physician Assistant Medicare: Not Enrolled in Medicare Practice Location: 340 N Main St, Southington, CT 06489 Phone: 860-628-5767 | |
Vickie Christine Gerdon, PA-C Physician Assistant Medicare: Medicare Enrolled Practice Location: 1131 West St, Southington, CT 06489 Phone: 860-621-7682 | |
Ramzia Julia Asheh, PA-C Physician Assistant Medicare: Medicare Enrolled Practice Location: 81 Meriden Ave, Emergency Department, Southington, CT 06489 Phone: 860-276-5000 | |
Emily Amanda Williams, PA-C Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 167 Main St, Southington, CT 06489 Phone: 860-426-0252 Fax: 860-426-0458 | |
Madeline Sadlowski, Physician Assistant Medicare: Not Enrolled in Medicare Practice Location: 74 Hightower Rd, Southington, CT 06489 Phone: 203-859-1563 |